A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL / Alliance A031801)
- Citation:
- 71
- Meeting Instance:
- KCRS 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180820, UG1CA233302 (ECOG-ACRIN); U10CA180888, UG1CA233340 (SWOG);
- Corr. Author:
- Authors:
- Rana R. McKay Pamela Atherton Heather Jacene Veronique Marcotte Archana Ajmera Shiva Baghaie Janet Koball Tyler Zemla Ronald C. Chen Atish Choudhury Joshua M. Lang Suzanne Cole Mamta Parikh Tareq Al Baghdadi Young Kwok Alan Tan Himisha Beltran Daniel George Michael J. Morris Toni K. Choueiri
- Networks:
- CA249, KANSAS, LAPS-MA036, LAPS-NC010, LAPS-NY016, LAPS-TN008, LAPS-TX011, LAPS-WI020, MCRC, MD015
- Study
- Alliance-A031801
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: